Literature DB >> 12842859

Protein interactions with nitric oxide synthases: controlling the right time, the right place, and the right amount of nitric oxide.

Bruce C Kone1, Teresa Kuncewicz, Wenzheng Zhang, Zhi-Yuan Yu.   

Abstract

Nitric oxide (NO) is a potent cell-signaling, effector, and vasodilator molecule that plays important roles in diverse biological effects in the kidney, vasculature, and many other tissues. Because of its high biological reactivity and diffusibility, multiple tiers of regulation, ranging from transcriptional to posttranslational controls, tightly control NO biosynthesis. Interactions of each of the major NO synthase (NOS) isoforms with heterologous proteins have emerged as a mechanism by which the activity, spatial distribution, and proximity of the NOS isoforms to regulatory proteins and intended targets are governed. Dimerization of the NOS isozymes, required for their activity, exhibits distinguishing features among these proteins and may serve as a regulated process and target for therapeutic intervention. An increasingly wide array of proteins, ranging from scaffolding proteins to membrane receptors, has been shown to function as NOS-binding partners. Neuronal NOS interacts via its PDZ domain with several PDZ-domain proteins. Several resident and recruited proteins of plasmalemmal caveolae, including caveolins, anchoring proteins, G protein-coupled receptors, kinases, and molecular chaperones, modulate the activity and trafficking of endothelial NOS in the endothelium. Inducible NOS (iNOS) interacts with the inhibitory molecules kalirin and NOS-associated protein 110 kDa, as well as activator proteins, the Rac GTPases. In addition, protein-protein interactions of proteins governing iNOS transcription function to specify activation or suppression of iNOS induction by cytokines. The calpain and ubiquitin-proteasome pathways are the major proteolytic systems responsible for the regulated degradation of NOS isozymes. The experimental basis for these protein-protein interactions, their functional importance, and potential implication for renal and vascular physiology and pathophysiology is reviewed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842859     DOI: 10.1152/ajprenal.00048.2003

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  79 in total

1.  Protection against puromycin aminonucleoside-induced chronic renal disease in the Wistar-Furth rat.

Authors:  Aaron Erdely; Gary Freshour; Cheryl Smith; Kevin Engels; Jean L Olson; Chris Baylis
Journal:  Am J Physiol Renal Physiol       Date:  2004-03-23

2.  Inhibitors caveolin-1 and protein kinase G show differential subcellular colocalization with Nitric oxide synthase.

Authors:  T J Adebola; Raj Usha
Journal:  Afr Health Sci       Date:  2011-12       Impact factor: 0.927

3.  Thioredoxin reductase linked to cytoskeleton by focal adhesion kinase reverses actin S-nitrosylation and restores neutrophil β(2) integrin function.

Authors:  Stephen R Thom; Veena M Bhopale; Tatyana N Milovanova; Ming Yang; Marina Bogush
Journal:  J Biol Chem       Date:  2012-07-09       Impact factor: 5.157

4.  Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles.

Authors:  Shiv K Gupta; Nicholas E Vlahakis
Journal:  Cell Adh Migr       Date:  2010-04-08       Impact factor: 3.405

Review 5.  Nitric oxide in plants: the biosynthesis and cell signalling properties of a fascinating molecule.

Authors:  Olivier Lamotte; Cécile Courtois; Laurent Barnavon; Alain Pugin; David Wendehenne
Journal:  Planta       Date:  2005-03-08       Impact factor: 4.116

Review 6.  eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?

Authors:  Rakesh C Kukreja; Lei Xi
Journal:  J Mol Cell Cardiol       Date:  2006-12-18       Impact factor: 5.000

Review 7.  Bioanalytical profile of the L-arginine/nitric oxide pathway and its evaluation by capillary electrophoresis.

Authors:  Dmitri Y Boudko
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-02-15       Impact factor: 3.205

8.  Central nicotinic acetylcholine receptor involved in Ca(2+) -calmodulin-endothelial nitric oxide synthase pathway modulated hypotensive effects.

Authors:  Pei-Wen Cheng; Pei-Jung Lu; Siang-Ru Chen; Wen-Yu Ho; Wen-Han Cheng; Ling-Zong Hong; Tung-Chen Yeh; Gwo-Ching Sun; Ling-Lin Wang; Michael Hsiao; Ching-Jiunn Tseng
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

9.  Binding of CAP70 to inducible nitric oxide synthase and implications for the vectorial release of nitric oxide in polarized cells.

Authors:  Inmaculada Navarro-Lérida; Mónica Martínez-Moreno; Iván Ventoso; Alberto Alvarez-Barrientos; Ignacio Rodríguez-Crespo
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

10.  Diabetes, lower extremity amputation, loss of protective sensation, and neuronal nitric oxide synthase associated protein in the chronic renal insufficiency cohort study.

Authors:  David J Margolis; Jayanta Gupta; Stephen R Thom; Raymond R Townsend; Peter A Kanetsky; Ole Hoffstad; Maryte Papdopoulos; Michael Fischer; Jeffrey R Schelling; Nandita Mitra
Journal:  Wound Repair Regen       Date:  2012-12-10       Impact factor: 3.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.